Coreline Soft Expands Screening Infrastructure Supply Based on Australia’s NLCSP

"Annual Screenings for 900,000 by 2030 Signals Start of Growth Curve"

Coreline Soft announced on February 27 that it has expanded its Oceania market reference based on Australia's National Lung Cancer Screening Program (NLCSP).

The Australian government has established lung cancer screening as a national health strategy, and a large-scale screening initiative targeting approximately 930,000 high-risk individuals is currently underway.

Coreline Soft, in collaboration with the local distributor Paragon Care, has supplied its "AVIEW LCS Plus" solution to "Lungscreen Australia," a hub institution responsible for reading images from more than 300 imaging centers. In addition, as of January 2026, the company has secured the Western Australian private imaging network PRC. As a result, Coreline Soft has built a supply infrastructure connecting approximately 400 imaging centers.

The NLCSP began its initial screening phase in 2025 and is scheduled to transition to an operational structure that combines follow-up and regular screenings starting in 2026. This process is expected to increase scan volumes. AVIEW LCS Plus supports simultaneous analysis of lung cancer, coronary artery calcification (CAC), and chronic obstructive pulmonary disease (COPD) from a single CT scan.

A representative from Coreline Soft stated, "We are working to establish AVIEW LCS Plus as the standard AI platform within Australia's screening infrastructure by supplying both national screening hubs and private networks."

This content was produced with the assistance of AI translation services.